Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03702010
Other study ID # EST-MED-2018-01
Secondary ID E.C.P.S. 18/1398
Status Completed
Phase N/A
First received
Last updated
Start date November 20, 2018
Est. completion date July 1, 2020

Study information

Verified date August 2021
Source Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Traditionally, pain relief through spinal cord stimulation has been associated with the appearance of paresthesia in the affected area. Several parameters are set to maximize the overexposure zone, such as frequency,and pulse width. Although this technique has improved pain in many patients, paresthesia itself can be uncomfortable. Traditionally, the occurrence of paresthesias has been considered to be a predictor of success in pain elimination, while the non-occurrence of paresthesias would indicate failure. So far, few studies have reported pain relief below the threshold of onset of paresthesia. Some clinical trials for pathologies other than the one considered in this study have achieved relief below the threshold by reducing the amplitude of the stimulus. Recently, however, it has been observed in a pilot study that, by increasing the frequency of spinal cord stimulation to 1 kilohertz, it is possible to significantly improve pain relief compared to less frequent conventional stimulation based on the occurrence of paresthesias. A recent review by the Cochrane Library concluded that conventional spinal cord stimulation for pain relief of Failed Back Surgery Syndrome (or FBSS) requires further clinical studies and better designs to demonstrate its superiority over other therapeutic options. Therefore, although spinal cord stimulation is accepted by the Food and Drug Administration (FDA) and the European Medicines Agency (EMA), new techniques are being introduced that offer better results in terms of pain relief. Among these techniques, there is the high frequency mode, which allows avoiding the annoying sensation of paresthesia that substitutes pain with the conventional technique. In order to provide greater rigour and scientific quality, the present study is proposed, in which the conventional spinal cord stimulation (CME) technique (control branch or CME) is compared with paresthesias and a standard frequency (60 hertz) with a high frequency (1000 hertz) EVOLVE system (Evolve workflow - standardized guidance to simplify the trial and implant experience and optimize patient outcomes) (experimental branch or EME) by means of a design with a high degree of scientific evidence, randomising the global sample of patients to each of the two branches of stimulation in the study (blind to the patient) and crossing the branches after a period of washing


Recruitment information / eligibility

Status Completed
Enrollment 27
Est. completion date July 1, 2020
Est. primary completion date July 1, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients over 18 years of age. - Patients with FBSS syndrome with leg pain or leg and back pain. - Get a score on the visual analogue scale (VAS) = 7. - Have received medical pharmacological treatment for at least 6 months after back surgery. - The patient has signed the informed consent form. Exclusion Criteria: - Patients under 18 years of age. - Patients who require a diathermic energy source (microwave, ultrasound or short wave). - Patients with a pacemaker. - Patients carrying a defibrillator. - Patient with a cochlear implant. - Patients with other active implanted devices. - Patients who are scheduled to have any of the following procedures during the study period: an MRI, defibrillation or cardioversion, electrocautery, lithotripsy, radiofrequency or microwave ablation, and any other high-frequency ultrasound procedure, - Women of childbearing age who do not use adequate contraception. - Pregnant or breastfeeding. - Participation in another trial. - Patients who have expressed a desire not to participate in the study and have not formed informed consent. - Patients with a failed spinal cord stimulation implant previously

Study Design


Intervention

Device:
spinal cord stimulation conventional
If the patient has been assigned to the branch of the CME control group, after mapping the search for the pain zone, the neurostimulator is programmed to conventional stimulation.
spinal cord stimulation experimental
If the patient has been randomized to the branch of the EME experimental group, after a mapping of the search for the pain zone, a 90% subthreshold stimulation is programmed.

Locations

Country Name City State
Spain Hospital San Pedro de Logroño Logroño La Rioja
Spain Complejo Asistencial Universitario de Salamanca Salamanca

Sponsors (2)

Lead Sponsor Collaborator
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León Instituto de Investigación Biomédica de Salamanca

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Comparing Visual Analogue Scale (VAS) Visual analogue scale (VAS) at the end of each test phase (either with conventional spinal cord stimulation or with EVOLVE). VAS consists of a 10 centimeter (cm) line, whose ends are defined as the extreme limits of pain (left end corresponds with the absence of pain and the right end with the maximum amount of pain).
The patient is asked to point out in the line the place that better correspond to his/her pain, ranging from 0 to 10.
Baseline, After first stimulation (5days), after washout and second stimulation (12 days), After 30-day follow-up (42 days)
Secondary Change (%) in VAS Scale at the End of Treatment. Change (%) in Visual Analogue Scale (VAS) at the end of treatment.
? = [(VAS Initial Visit - VAS Final Visit) / VAS initial visit] *100
Please note that positive values indicate a decrease in the VAS scale, which would indicate pain relief, as it was calculated as the value at the earlier time point minus the value at the later time point.
After first stimulation (Five days after baseline), After second stimulation (12 days after baseline), at the end of follow-up (42 days after baseline)
Secondary Evaluation Disability Oswestry Disability Index of the patients: it is a questionnaire consisting of 10 questions with 6 possible answers each. Every answer gives a punctuation from 0 (less disability) to 5 (more disability).
This scale is expressed in percentage in which 0 percentage (%) would the least disability and 100 percentage (%) would represent the maximum disability.
Baseline, After first stimulation (+5 days), After washout and second stimulation (+12 days), at the end of follow-up (+42days)
Secondary Number of Participants With Adverse Events in Each Arm Considering as an adverse event those that result in death, or in severe harm to patient's health (lesion that threatens life, permanent harm on an organ or corporal function, or process that needs a medical or surgical intervention to avoid permanent harm) 42 days from baseline
See also
  Status Clinical Trial Phase
Completed NCT01701804 - The Effectiveness of Non-surgical Integrative Package on Failed Back Surgery Syndrome
Not yet recruiting NCT01185665 - Predicting Outcome of Transcutaneous Electrical Nerve Stimulator (TENS) in Failed Back Surgery Syndrome N/A
Terminated NCT00974623 - Bone Graft Materials Observational Registry N/A
Recruiting NCT01181817 - Evaluation of the Brain Activity During Spinal Cord Stimulation in Failed Back Surgery Syndrome Using Functional MRI and MRS N/A
Recruiting NCT04732325 - Sensory Testing of Multiple Forms of Spinal Cord Stimulation for Pain N/A
Completed NCT05018377 - Effectiveness and Safety of Percutaneous Adhesiolysis Using Rac'z Catheter Versus Navi Catheter in Management of Failed Back Surgery Syndrome N/A
Not yet recruiting NCT04268602 - The Effect of Intradermal Local Anesthetic Injection in FBSS (Failed Back Surgery Syndrome) N/A
Recruiting NCT03957395 - Comparison of Effectiveness of Tonic, High Frequency and Burst Spinal Cord Stimulation in Chronic Pain Syndromes N/A
Completed NCT04121104 - Electrodermal Activity and Respiration in Patients Treated With Spinal Cord Stimulation N/A
Recruiting NCT05068011 - Differential Target Multiplexed Spinal Cord Stimulation
Not yet recruiting NCT06034041 - The Effect of Mediclore as an Anti-adhesion Agent and Safety in Full-endoscopic Spine Surgery: a Preliminary Study Phase 4
Completed NCT02837822 - Effects of Spinal Cord Stimulation on Sensory Perceptions of Chronic Pain Patients N/A
Completed NCT01966250 - Electroacupuncture as a Complement to Usual Care for Patients With Non-acute Pain After Back Surgery N/A
Completed NCT00018876 - Low-Dose Radiation to Prevent Complications of Back Surgery Phase 1
Completed NCT03523000 - Determining the Prognostic Value of Continuous Intrathecal Infusion Phase 4
Completed NCT01776749 - Subcutaneous Stimulation as Add on Therapy to SCS toTreat Low Back Pain in FBSS N/A
Recruiting NCT04244669 - Impact of the SCS With Different Waveforms Over the Quality of Life (SCS-Quality) N/A
Completed NCT02974101 - AdaptiveStim Objectifying Subjective Pain Questionnaires N/A
Terminated NCT01990287 - SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study N/A
Terminated NCT01711619 - SubQStim: A Post-market Study of Subcutaneous Nerve Stimulation in Failed Back Surgery Syndrome (FBSS) Patients N/A